腎除神経(腎デナベーション):企業と競争環境...市場調査レポートについてご紹介

【英文タイトル】MediPoint: Renal Denervation - Current and Future Players

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 12
2.1 Overview 12
2.2 Catalyst 13
3 Marketed Products 14
3.1 Overview 14
3.2 Market Share 16
3.2.1 US Market Share, 2013 and 2016 16
3.2.2 France Market Share, 2013 and 2016 17
3.2.3 Germany Market Share, 2013 and 2016 19
3.2.4 Italy Market Share, 2013 and 2016 21
3.2.5 Spain Market Share, 2013 and 2016 23
3.2.6 UK Market Share, 2013 and 2016 25
3.2.7 Japan Market Share, 2013 and 2016 27
3.2.8 Brazil Market Share, 2013 and 2016 28
3.2.9 India Market Share, 2013 and 2016 29
3.2.10 China Market Share, 2013 and 2016 30
3.3 Allegra Renal Denervation System (Terumo/AngioCare) 31
3.3.1 Overview 31
3.3.2 Safety and Efficacy 32
3.3.3 SWOT Analysis 33
3.4 EnligHTN Renal Denervation System (St. Jude Medical) 34
3.4.1 Overview 34
3.4.2 Safety and Efficacy 35
3.4.3 SWOT Analysis 37
3.5 OneShot Renal Denervation System (Covidien) 38
3.5.1 Overview 38
3.5.2 Safety and Efficacy 39
3.5.3 SWOT Analysis 40
3.6 Paradise Renal Denervation System (ReCor Medical) 41
3.6.1 Overview 41
3.6.2 Safety and Efficacy 42
3.6.3 SWOT Analysis 43
3.7 Symplicity Renal Denervation System (Medtronic) 44
3.7.1 Overview 44
3.7.2 Safety and Efficacy 46
3.7.3 SWOT Analysis 49
3.8 Vessix Renal Denervation System (Boston Scientific Corporation) 50
3.8.1 Overview 50
3.8.2 Safety and Efficacy 51
3.8.3 SWOT Analysis 52
4 Pipeline Products 53
4.1 Overview 53
4.2 Beta-Cath System (Best Medical International) 53
4.2.1 Overview 53
4.2.2 Safety and Efficacy 53
4.2.3 SWOT Analysis 54
4.3 Bullfrog MicroFusion Catheter (Mercator MedSystems) 55
4.3.1 Overview 55
4.3.2 Safety and Efficacy 56
4.3.3 SWOT Analysis 56
4.4 Chemical Denervation System (Kipprokration Hospital) 57
4.4.1 Overview 57
4.4.2 Safety and Efficacy 57
4.4.3 SWOT Analysis 58
4.5 Cryoablation System (Cryomend) 59
4.5.1 Overview 59
4.5.2 Safety and Efficacy 59
4.5.3 SWOT Analysis 60
4.6 Kona Surround Sound System (Kona Medical) 61
4.6.1 Overview 61
4.6.2 Safety and Efficacy 62
4.6.3 SWOT Analysis 63
4.7 Magnetic Nanoparticles (ApexNano) 64
4.7.1 Overview 64
4.7.2 Safety and Efficacy 64
4.7.3 SWOT Analysis 65
4.8 Perivascular Renal Denervation System (Ablative Solutions) 66
4.8.1 Overview 66
4.8.2 Safety and Efficacy 66
4.8.3 SWOT Analysis 67
4.9 Sound 360 Ultrasonic Renal Denervation System (Sound Interventions) 68
4.9.1 Overview 68
4.9.2 Safety and Efficacy 69
4.9.3 SWOT Analysis 70
4.10 Symple Surgical System (Symple Surgical) 71
4.10.1 Overview 71
4.10.2 Safety and Efficacy 71
4.10.3 SWOT Analysis 71
4.11 Tivus System (Cardiosonic) 72
4.11.1 Overview 72
4.11.2 Safety and Efficacy 73
4.11.3 SWOT Analysis 74
4.12 Celsius ThermoCool System (Cordis/Johnson & Johnson) 75
4.12.1 Overview 75
4.12.2 Safety and Efficacy 75
4.12.3 SWOT Analysis 76
4.13 Northwind Medical System (Northwind Medical) 77
4.13.1 Overview 77
4.13.2 Safety and Efficacy 77
4.13.3 SWOT Analysis 77
4.14 Verve Medical System (Verve Medical) 78
4.14.1 Overview 78
4.14.2 Safety and Efficacy 78
4.14.3 SWOT Analysis 79
5 Current and Future Players 80
5.1 Trends in Corporate Strategy 80
5.2 Company Profiles 81
5.2.1 Ablative Solutions 81
5.2.2 ApexNano 84
5.2.3 Best Medical International 87
5.2.4 Boston Scientific Corporation 89
5.2.5 Cardiosonic 92
5.2.6 Covidien 95
5.2.7 Cordis Corporation and Johnson & Johnson 98
5.2.8 Cryomend 101
5.2.9 Kona Medical 103
5.2.10 Medtronic 106
5.2.11 Mercator MedSystems 109
5.2.12 Northwind Medical 112
5.2.13 ReCor Medical 114
5.2.14 Sound Interventions 117
5.2.15 St. Jude Medical 120
5.2.16 Symple Surgical 123
5.2.17 Terumo Corporation 125
5.2.18 Verve Medical 128
6 Appendix 131
6.1 Bibliography 131
6.2 Abbreviations 138
6.3 Report Methodology 141
6.3.1 Overview 141
6.3.2 Coverage 141
6.3.3 Primary Research 142
6.3.4 Secondary Research 143
6.3.5 Forecasting Methodology 143
6.4 Key Opinion Leaders Included in this Study 144
6.5 About the Authors 145
6.5.1 Joseph A. Gregory, Analyst, Surgical Devices 145
6.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 145
6.6 Global Head of Healthcare 146
6.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 146
6.7 About MediPoint 147
6.8 About GlobalData 147
6.9 Disclaimer 147


【レポート販売概要】

■ タイトル:腎除神経(腎デナベーション):企業と競争環境
■ 英文:MediPoint: Renal Denervation - Current and Future Players
■ 発行日:2013年10月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162524
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。